巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Renovacor

RCOR
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Renovacor - 延遲價格・最後更新於 21/01 12:15
最高位
7.200
最低位
7.050
開市價
--
前收市價
7.540
成交量(千)
0.52
成交額(百萬)
0.03
買入
--
賣出
--
每手股數
--
市值(百萬)
121.66
市盈率
--
息率
--
差價
--
52週高低
11.120 - 6.850
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Renovacor
證券代碼
RCOR.US
所屬板塊
Biotechnology
公司業務
Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
發行量
16756042
公司總部
717 Braeburn Lane Narberth
公司網址
https://www.renovacor.com
暫無內容

關於

Renovacor(RCOR.US)所屬的行業板塊為Biotechnology。
Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
詳細公司背景可參考: https://www.renovacor.com